These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29743351)

  • 41. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
    Trilck M; Hübner R; Frech MJ
    Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors:
    Shigyo M; Kobayashi Y; Platoshyn O; Marsala S; Kato T; Takamura N; Yoshida K; Kishino A; Bravo-Hernandez M; Juhas S; Juhasova J; Studenovska H; Proks V; Ciacci JD; Marsala M
    Cell Transplant; 2023; 32():9636897231163232. PubMed ID: 36959733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone morphogenetic proteins prevent bone marrow stromal cell-mediated oligodendroglial differentiation of transplanted adult neural progenitor cells in the injured spinal cord.
    Sandner B; Rivera FJ; Caioni M; Nicholson L; Eckstein V; Bogdahn U; Aigner L; Blesch A; Weidner N
    Stem Cell Res; 2013 Sep; 11(2):758-71. PubMed ID: 23770801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.
    Nori S; Okada Y; Nishimura S; Sasaki T; Itakura G; Kobayashi Y; Renault-Mihara F; Shimizu A; Koya I; Yoshida R; Kudoh J; Koike M; Uchiyama Y; Ikeda E; Toyama Y; Nakamura M; Okano H
    Stem Cell Reports; 2015 Mar; 4(3):360-73. PubMed ID: 25684226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
    PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord.
    Lepore AC; Fischer I
    Exp Neurol; 2005 Jul; 194(1):230-42. PubMed ID: 15899260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
    Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
    Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological Issues After Stem Cell-Based β Cell Replacement.
    Sordi V; Pellegrini S; Piemonti L
    Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ischemia, immunosuppression, and SSEA-1-negative cells all contribute to tumors resulting from mouse embryonic stem cell-derived neural progenitor transplantation.
    Guan Y; Zou H; Chen X; Zhao C; Wang J; Cai Y; Chan P; Chen L; Zhang YA
    J Neurosci Res; 2014 Jan; 92(1):74-85. PubMed ID: 24123213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic potential of human induced pluripotent stem cells in experimental stroke.
    Chang DJ; Lee N; Park IH; Choi C; Jeon I; Kwon J; Oh SH; Shin DA; Do JT; Lee DR; Lee H; Moon H; Hong KS; Daley GQ; Song J
    Cell Transplant; 2013; 22(8):1427-40. PubMed ID: 23044029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of induced pluripotent stem cells.
    Zhao T; Zhang ZN; Rong Z; Xu Y
    Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury.
    Karimi-Abdolrezaee S; Eftekharpour E; Wang J; Morshead CM; Fehlings MG
    J Neurosci; 2006 Mar; 26(13):3377-89. PubMed ID: 16571744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors.
    Bohaciakova D; Hruska-Plochan M; Tsunemoto R; Gifford WD; Driscoll SP; Glenn TD; Wu S; Marsala S; Navarro M; Tadokoro T; Juhas S; Juhasova J; Platoshyn O; Piper D; Sheckler V; Ditsworth D; Pfaff SL; Marsala M
    Stem Cell Res Ther; 2019 Mar; 10(1):83. PubMed ID: 30867054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord.
    Lepore AC; Bakshi A; Swanger SA; Rao MS; Fischer I
    Brain Res; 2005 May; 1045(1-2):206-16. PubMed ID: 15910779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of neural stem cells and progenitors: neuronal production and grafting applications.
    Bonner JF; Haas CJ; Fischer I
    Methods Mol Biol; 2013; 1078():65-88. PubMed ID: 23975822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation of porcine embryonic stem cells and their derived neuronal progenitors in a spinal cord injury rat model.
    Yang JR; Liao CH; Pang CY; Huang LL; Chen YL; Shiue YL; Chen LR
    Cytotherapy; 2013 Feb; 15(2):201-8. PubMed ID: 23245953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical Validation of Multilevel Intraparenchymal Stem Cell Therapy in the Porcine Spinal Cord.
    Gutierrez J; Lamanna JJ; Grin N; Hurtig CV; Miller JH; Riley J; Urquia L; Avalos P; Svendsen CN; Federici T; Boulis NM
    Neurosurgery; 2015 Oct; 77(4):604-12; discussion 612. PubMed ID: 26134596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke.
    Lee IH; Huang SS; Chuang CY; Liao KH; Chang LH; Chuang CC; Su YS; Lin HJ; Hsieh JY; Su SH; Lee OK; Kuo HC
    Sci Rep; 2017 May; 7(1):1943. PubMed ID: 28512358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
    Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing.
    Nagoshi N; Khazaei M; Ahlfors JE; Ahuja CS; Nori S; Wang J; Shibata S; Fehlings MG
    Stem Cells Transl Med; 2018 Nov; 7(11):806-818. PubMed ID: 30085415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.